Post-IPO Equity Life Science Companies

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.

Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.

Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Forte Biosciences is a biotechnology company that focuses on dermatology.

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.